James Loerop
2020
In 2020, James Loerop earned a total compensation of $1M as EVP, Business Development and Strategic Planning at Anika Therapeutics, a 30% decrease compared to previous year.
Compensation breakdown
| Bonus | $171,703 |
|---|---|
| Salary | $381,563 |
| Stock Awards | $464,449 |
| Other | $22,156 |
| Total | $1,039,871 |
Loerop received $464.4K in stock awards, accounting for 45% of the total pay in 2020.
Loerop also received $171.7K in bonus, $381.6K in salary and $22.2K in other compensation.
Rankings
In 2020, James Loerop's compensation ranked 8,461st out of 13,090 executives tracked by ExecPay. In other words, Loerop earned more than 35.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,461 out of 13,090 | 35th |
Division Manufacturing | 3,599 out of 5,621 | 36th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 458 out of 799 | 43rd |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 275 out of 495 | 44th |
Industry Surgical and Medical Instruments and Apparatus | 179 out of 313 | 43rd |
Source: SEC filing on April 30, 2021.
Loerop's colleagues
We found six more compensation records of executives who worked with James Loerop at Anika Therapeutics in 2020.
2020
Cheryl Blanchard
Anika Therapeutics
Chief Executive Officer
2020
Michael Levitz
Anika Therapeutics
Chief Financial Officer
2020
David Colleran
Anika Therapeutics
General Counsel
2020
Sylvia Cheung
Anika Therapeutics
Chief Financial Officer
2020
Thomas Finnerty
Anika Therapeutics
EVP, Human Resources
2020
Joseph Darling
Anika Therapeutics